Jan Petz

2.7k total citations · 1 hit paper
18 papers, 1.9k citations indexed

About

Jan Petz is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jan Petz has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 11 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Jan Petz's work include Liver Diseases and Immunity (14 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). Jan Petz is often cited by papers focused on Liver Diseases and Immunity (14 papers), Liver Disease Diagnosis and Treatment (11 papers) and Liver Disease and Transplantation (5 papers). Jan Petz collaborates with scholars based in United States, Belgium and Australia. Jan Petz's co-authors include Keith D. Lindor, Roberta A. Jorgensen, Jill C. Keach, Paul Angulo, Tousif M. Pasha, Kathleen M. Egan, Kelly W. Burak, Kris V. Kowdley, Timothy M. McCashland and Denise M. Harnois and has published in prestigious journals such as Hepatology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Jan Petz

16 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #

2009 478 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Petz United States	16	1.4k	1.1k	966	692	247	18	1.9k
Edwyn M Harrison United States	13	1.1k 0.8×	1.0k 0.9×	1.2k 1.3×	573 0.8×	354 1.4×	16	2.1k
Keith D. Lindor United States	14	1.0k 0.7×	530 0.5×	842 0.9×	297 0.4×	119 0.5×	16	1.2k
S Iwatsuki United States	20	735 0.5×	743 0.7×	426 0.4×	163 0.2×	229 0.9×	47	1.3k
Alec Avgerinos Greece	23	775 0.6×	870 0.8×	713 0.7×	273 0.4×	172 0.7×	57	1.6k
Emmanouil Sinakos Greece	18	766 0.6×	544 0.5×	739 0.8×	310 0.4×	147 0.6×	63	1.3k
Francisco Sánchez‐Bueno Spain	22	602 0.4×	1.0k 0.9×	262 0.3×	327 0.5×	231 0.9×	111	1.6k
Kapil Chopra United States	18	556 0.4×	356 0.3×	674 0.7×	190 0.3×	121 0.5×	39	1.2k
Gerda Rudolph Germany	17	983 0.7×	829 0.8×	578 0.6×	590 0.9×	302 1.2×	19	1.3k
Thomas J. Rosenthal United States	8	634 0.5×	1.0k 1.0×	175 0.2×	286 0.4×	73 0.3×	10	1.4k
Denis Bernard France	16	605 0.4×	825 0.8×	237 0.2×	151 0.2×	195 0.8×	40	1.1k

Countries citing papers authored by Jan Petz

Since Specialization

Citations

This map shows the geographic impact of Jan Petz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Petz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Petz more than expected).

Fields of papers citing papers by Jan Petz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Petz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Petz. The network helps show where Jan Petz may publish in the future.

Co-authorship network of co-authors of Jan Petz

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Petz. A scholar is included among the top collaborators of Jan Petz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Petz. Jan Petz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Tabibian, James H., Andrea A. Gossard, Mounif El‐Youssef, et al.. (2014). Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis. American Journal of Therapeutics. 24(1). e56–e63. 55 indexed citations

Tabibian, James H., Emma Weeding, Roberta A. Jorgensen, et al.. (2013). Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study. Alimentary Pharmacology & Therapeutics. 37(6). 604–612. 182 indexed citations

Eaton, John E., Marina G. Silveira, Darrell S. Pardi, et al.. (2011). High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 106(9). 1638–1645. 180 indexed citations

Imam, Mohamad, Emmanouil Sinakos, Andrea A. Gossard, et al.. (2011). High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis. Alimentary Pharmacology & Therapeutics. 34(10). 1185–1192. 59 indexed citations

Martin, Camilia R., Paola G. Blanco, Jill C. Keach, et al.. (2011). The safety and efficacy of oral docosahexaenoic acid supplementation for the treatment of primary sclerosing cholangitis – a pilot study. Alimentary Pharmacology & Therapeutics. 35(2). 255–265. 32 indexed citations

Levy, Cynthia, Joy Peter, David R. Nelson, et al.. (2010). Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Alimentary Pharmacology & Therapeutics. 33(2). 235–242. 133 indexed citations

Adams, Leon A., Paul Angulo, Jan Petz, Jill C. Keach, & Keith D. Lindor. (2010). A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis. Hepatology International. 4(3). 628–633. 21 indexed citations

Treeprasertsuk, Sombat, Kris V. Kowdley, Velimir A. Luketic, et al.. (2009). The predictors of the presence of varices in patients with primary sclerosing cholangitis†. Hepatology. 51(4). 1302–1310. 18 indexed citations

Lindor, Keith D., Kris V. Kowdley, Velimir A. Luketic, et al.. (2009). High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #. Hepatology. 50(3). 808–814. 478 indexed citations breakdown →

10.

Burak, Kelly W., Paul Angulo, Tousif M. Pasha, et al.. (2004). Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 99(3). 523–526. 354 indexed citations

11.

Kim, W. Ray, Keith D. Lindor, Michael Malinchoc, et al.. (2000). Reliability and Validity of the Niddk–Qa Instrument in the Assessment of Quality of Life in Ambulatory Patients With Cholestatic Liver Disease. Hepatology. 32(5). 924–929. 37 indexed citations

12.

Heathcote, E. Jenny, Julie A. Stone, Karen Cauch‐Dudek, et al.. (1999). Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver Transplantation and Surgery. 5(4). 269–274. 22 indexed citations

13.

Kim, W. Ray, John J. Poterucha, Russell H. Wiesner, et al.. (1999). The Relative Role of the Child–Pugh Classification and the Mayo Natural History Model in the Assessment of Survival in Patients With Primary Sclerosing Cholangitis. Hepatology. 29(6). 1643–1648. 96 indexed citations

14.

Ricci, P, Terry M. Therneau, Michael Malinchoc, et al.. (1997). A Prognostic Model for the Outcome of Liver Transplantation in Patients With Cholestatic Liver Disease. Hepatology. 25(3). 672–677. 78 indexed citations

15.

Kovács, Kálmán, et al.. (1986). [Idiopathic thrombocytopenic purpura and pregnancy].. PubMed. 127(12). 713–5.

16.

Bowyer, Brad A., C. Richard Fleming, J. Ludwig, Jan Petz, & D.B. McGill. (1985). Does Long‐Term Home Parenteral Nutrition in Adult Patients Cause Chronic Liver Disease?. Journal of Parenteral and Enteral Nutrition. 9(1). 11–17. 111 indexed citations

17.

Fleming, C. Richard, John McCall, John F. O’Brien, et al.. (1984). Selenium Status in Patients Receiving Home Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition. 8(3). 258–262. 31 indexed citations

18.

Fleming, C., et al.. (1983). O.23 Fate of gut failure patients on home parenteral nutrition (HPN). Clinical Nutrition. 2. 14–14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact